Decorin (DCN) Downregulation Activates Breast Stromal Fibroblasts and Promotes Their Pro-Carcinogenic Effects through the IL-6/STAT3/AUF1 Signaling
Cells · 14.04.2024 · 13 (8) · 680
DOI: 10.3390/cells13080680 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 14.04.2024. Verfasst von Wafaa A Aljagthmi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia. Hauptthemen laut MEDLINE: Decorin, STAT3 Transcription Factor, Signal Transduction, Interleukin-6. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Decorin (DCN), a member of the small leucine-rich proteoglycan gene family, is secreted from stromal fibroblasts with non-cell-autonomous anti-breast-cancer effects. Therefore, in the present study, we sought to elucidate the function of decorin in breast stromal fibroblasts (BSFs). We first showed DCN downregulation in active cancer-associated fibroblasts (CAFs) compared to their adjacent tumor counterpart fibroblasts at both the mRNA and protein levels. Interestingly, breast cancer cells and the recombinant IL-6 protein, both known to activate fibroblasts in vitro, downregulated DCN in BSFs. Moreover, specific DCN knockdown in breast fibroblasts modulated the expression/secretion of several CAF biomarkers and cancer-promoting proteins (α-SMA, FAP- α, SDF-1 and IL-6) and enhanced the invasion/proliferation abilities of these cells through activation of the STAT3/AUF1 signaling. Furthermore, DCN-deficient fibroblasts promoted the epithelial-to-mesenchymal transition and stemness processes in BC cells in a paracrine manner, which increased their resistance to cisplatin. These DCN-deficient fibroblasts also enhanced angiogenesis and orthotopic tumor growth in mice in a paracrine manner. On the other hand, ectopic expression of DCN in CAFs suppressed their active features and their paracrine pro-carcinogenic effects. Together, the present findings indicate that endogenous DCN suppresses the pro-carcinogenic and pro-metastatic effects of breast stromal fibroblasts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia.
- Department of Zoology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Saud University, Riyadh 11495, Saudi Arabia.
- Department of Comparative Medicine, King Faisal Specialist Hospital and Research Center, Riyadh 11211, Saudi Arabia.
ORCID-Profile: Maha H Daghestani, Layla A Al-Kharashi
Zitieren
APA
Aljagthmi, W. A., Alasmari, M. A., Daghestani, M. H., Al-Kharashi, L. A., Al-Mohanna, F. H., & Aboussekhra, A. (2024). Decorin (DCN) Downregulation Activates Breast Stromal Fibroblasts and Promotes Their Pro-Carcinogenic Effects through the IL-6/STAT3/AUF1 Signaling. Cells, 13(8), 680. https://doi.org/10.3390/cells13080680
Vancouver
Aljagthmi WA, Alasmari MA, Daghestani MH, Al-Kharashi LA, Al-Mohanna FH, Aboussekhra A. Decorin (DCN) Downregulation Activates Breast Stromal Fibroblasts and Promotes Their Pro-Carcinogenic Effects through the IL-6/STAT3/AUF1 Signaling. Cells. 2024;13(8):680. doi:10.3390/cells13080680
BibTeX
@article{Aljagthmi2024,
author = {Aljagthmi, Wafaa A and Alasmari, Manal A and Daghestani, Maha H and Al-Kharashi, Layla A and Al-Mohanna, Falah H and Aboussekhra, Abdelilah},
title = {Decorin (DCN) Downregulation Activates Breast Stromal Fibroblasts and Promotes Their Pro-Carcinogenic Effects through the IL-6/STAT3/AUF1 Signaling},
journal = {Cells},
year = {2024},
volume = {13},
number = {8},
pages = {680},
doi = {10.3390/cells13080680}
}
EUVIMED